José Antonio López‐Guerrero

Consejo Superior de Investigaciones Científicas — Spain

Medicine · Health Sciences

45h-index9.2kcitations326works2.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Sarcoma Diagnosis and Treatment(59), Prostate Cancer Treatment and Research(31), Gastrointestinal Tumor Research and Treatment(31), Ovarian cancer diagnosis and treatment(26), Cancer Genomics and Diagnostics(22)

Publications325 total

From HSV-2 to HSV-1: A change in the epidemiology of genital herpes
Journal of Infection·2025· 4 citedOpen Access
Discovery of a Baloxavir‐Inspired Endonuclease Inhibitor That Prevents Herpes Simplex Virus 1 Replication in Cell Culture and In Vivo
Advanced Science·2025Open Access
1107P Incidence of germline BRCA1/2 mutations in high-grade serous epithelial ovarian cancer (EOC): Final results of the GEICO 60-O/BORNEO study
Annals of Oncology·2025
294MO Preoperative window-of-opportunity study with giredestrant or tamoxifen (tam) in premenopausal women with estrogen receptor-positive (ER+)/human epidermal growth factor receptor 2-negative (HER2-) and Ki67≥10% early breast cancer (EBC): The EMPRESS study
Annals of Oncology·2025· 1 cited
Uterine Myxoid Mesenchymal Tumor With a Novel <i>SS18::VEZF1</i> Gene Fusion, Lacking Worrisome Histological Features
Genes Chromosomes and Cancer·2025Open Access
Polyclonal LC3B Antibodies Generate Non-Specific Staining in the Nucleus of Herpes Simplex Virus Type 1-Infected Cells: Caution in the Interpretation of LC3 Staining in the Immunofluorescence Analysis of Viral Infections
International Journal of Molecular Sciences·2025Open Access
Prevention of sacituzumab govitecan-related neutropenia and diarrhea in patients with HER2-negative advanced breast cancer (PRIMED): an open-label, single-arm, phase 2 trial
EClinicalMedicine·2025· 7 citedOpen Access
Atezolizumab plus paclitaxel and bevacizumab as first-line treatment of advanced triple-negative breast cancer: the ATRACTIB phase 2 trial
Nature Medicine·2025· 12 citedOpen Access
International Registry of thyroid cancer in Latin American (CaTaLiNA): epidemiology, clinical and follow-up study protocol in Latin American countries during the period 2023–2028
BMJ Open·2025Open Access
Optimizing an NGS low-pass–based method to detect genomic instability as a PARP inhibitor predictive biomarker in high-grade serous ovarian cancer.
Journal of Clinical Oncology·2025
Association of socioeconomic status with secondary primary malignancy risk and mortality.
Journal of Clinical Oncology·2025
64 Integration of an Overall Survival-Based Machine Learning Score and ImmunoScore as an Ancillary Tool for Predicting Immunotherapy Response in Sarcomas
Laboratory Investigation·2025Open Access
Immune Modulatory Effects of Vitamin D on Herpesvirus Infections
International Journal of Molecular Sciences·2025· 3 citedOpen Access
Five Years Of Real-Life Data In Gynaecological Cancers: A Multicenter Clinical Registry With Associated Samples (GEICO 81-T)
International Journal of Gynecological Cancer·2025
Primary Visceral Ewing Sarcoma (Gastric and Bladder) with KIT Expression: A Report of Two Patients and a Differential Diagnostic Approach
International Journal of Surgical Pathology·2025
Prevention of Sacituzumab Govitecan-Related Neutropenia and Diarrhea in Patients with Her2-Negative Advanced Breast Cancer (PRIMED): An Open-Label, Single-Arm, Phase 2 Trial
SSRN Electronic Journal·2025Open Access
Exploring Visual-Language Models as a Powerful Tool in the Diagnosis of Ewing Sarcoma
Smart innovation, systems and technologies·2025
Human Coronavirus 229E Uses Clathrin-Mediated Endocytosis as a Route of Entry in Huh-7 Cells
Biomolecules·2024· 3 citedOpen Access
Comparative profiling of whole-cell and exosome samples reveals protein signatures that stratify breast cancer subtypes
Cellular and Molecular Life Sciences·2024· 9 citedOpen Access
Shared germline genomic variants in two patients with double primary gastrointestinal stromal tumours (GISTs)
Journal of Medical Genetics·2024
page 1 of 17Next →

Frequent Co-authors

Antonio Llombart‐Bosch(11), Andrés Poveda(10), Javier Martín‐Broto(8), B. Llombart(8), Antonio Fernández‐Serra(8), Raquel Bello‐Morales(8), Luis Rubio(7), Onofre Sanmartín(6), J. Rubio‐Briones(6), C. Serra‐Guillén(5), Xavier García del Muro(5), Antonio Pellı́n(5), Ana Calatrava(5), Zaida García‐Casado(5), Antonio Gutiérrez(4), Carlos Monteagudo(4), Ignacio Romero(4), Carlos Guillén(4), Irene Casanova‐Salas(4), Celia Requena(4)